TY  - GEN
AU  - Waddington,Cs
AU  - Andrews,N
AU  - Hoschler,K
AU  - Walker,Wt
AU  - Oeser,C
AU  - Reiner,A
AU  - John,T
AU  - Wilkins,S
AU  - Casey,M
AU  - Eccleston,Pe
AU  - Allen,Rj
AU  - Okike,I
AU  - Ladhani,S
AU  - Sheasby,E
AU  - Waight,P
AU  - Collinson,Ac
AU  - Heath,Pt
AU  - Finn,A
AU  - Faust,Sn
AU  - Snape,Md
AU  - Miller,E
AU  - Pollard,Aj
TI  - Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
SN  - 2046-4924
PY  - 2011///0207
KW  - Antibodies, Viral
KW  - biosynthesis
KW  - Child
KW  - Child, Preschool
KW  - Disease Outbreaks
KW  - statistics & numerical data
KW  - Drug Combinations
KW  - Emulsions
KW  - Female
KW  - Humans
KW  - Immunization Programs
KW  - Infant
KW  - Influenza A Virus, H1N1 Subtype
KW  - immunology
KW  - Influenza Vaccines
KW  - administration & dosage
KW  - Influenza, Human
KW  - prevention & control
KW  - Male
KW  - Polysorbates
KW  - Program Evaluation
KW  - Squalene
KW  - United Kingdom
KW  - alpha-Tocopherol
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3310/hta14460-01
ER  -